week one on tirzepatide TrimRX Starting Tirzepatide? Here's What to

BMI showed only a slight, non-significant reduction from 34.0 to 33.9

Find out all about this new weight loss treatment in Beverly Hills by calling R3 Anti-Aging & Medspa at (424) 382-1074

These medications are primarily prescribed for two distinct clinical indications

Tirzepatide, a dual GLP-1 and GIP receptor agonist, reduces hunger signals and delays gastric emptyingwhich means you'll eat less food overall

Participants were adults with: Obesity (BMI 30 kg/m) or Overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease No diabetes diagnosis Participants were randomized 1:1 to receive either: Maximum tolerated dose of Zepbound (10 mg or 15 mg) Maximum tolerated dose of Wegovy (1.7 mg or 2.4 mg) The study cohort had a mean age of 44.7 years, 64.7% were women, and participants had an average body weight of 249 pounds with a mean BMI of 39.4 kg/m

If a sore is suspicious or doesnt look like a canker sore, your doctor may recommend a biopsy to identify the lesion